SETTING MEANINGFUL GOALS IN THE
MANAGEMENT OF mBC WHITE PAPER
The Patient Care Perspectives section of the mBC Global Decade Report highlighted the necessity for further insights into the decision-making process between patients and physicians regarding goals of treatment throughout the metastatic breast cancer (mBC) patient journey continuum.
A primary research study was commissioned by Pfizer Inc. to investigate further, inform recommendations for improvements to understand the goals of mBC treatment beyond clinical outcomes alone, and to compare patient and physician perspectives.
Additional insights from an international expert committee of 5 key opinion leaders from Switzerland, Germany, USA and Japan informed the interpretation of the research findings and have shaped a series of key recommendations based on clinical experience.